Advertisement

Topics

Immune Pharmaceuticals Inc. Company Profile

06:42 EDT 26th June 2019 | BioPortfolio

Immune Pharmaceuticals Inc. (NASDAQ:IMNP) is dedicated to alleviating the burden of patients suffering from autoimmune diseases by developing novel immunotherapeutic agents. Immune's lead product candidate, bertilimumab, is in Phase 2 clinical development for bullous pemphigoid, an orphan autoimmune dermatological condition, and for ulcerative colitis. Other potential relevant indications for bertilimumab include atopic dermatitis, Crohn's disease, severe asthma and Non-Alcoholic Steato-Hepatitis (NASH). Also, Immune's pipeline includes topical nano-formulated cyclosporine-A for the treatment of psoriasis and atopic dermatitis and AmiKet™ and AmiKet™ Nano™ for the treatment of neuropathic pain.


News Articles [1499 Associated News Articles listed on BioPortfolio]

The right drug, to the right patient, at the right price

Immune Pharmaceuticals Inc. (NASDAQ: IMNP) is developing precision immunotherapies for inflammatory diseases and cancer. Immune’s core programme includes Bertilimumab (currently in phase II in ulcer...

Immune Profiling Kit

Cofactor Genomics This RNA-based ImmunoPrism™ Immune Profiling Kit was developed for laboratories wishing to derive the immune composition of tumor samples. The tumor’s immune composition is provi...

X4 Pharmaceuticals Presents Additional Positive Phase 2 Results for X4P 001 in WHIM Syndrome, Continues on Path to Initiation of Phase 3 Trial

CAMBRIDGE, MA – December 1, 2018 – X4 Pharmaceuticals, a clinical stage biotechnology company developing novel CXCR4 allosteric antagonist drugs to improve immune cell trafficking to treat...

How to reinvigorate exhausted immune cells and stop cancer along the way

(University of Pennsylvania School of Medicine) In cancer and chronic infections immune balance can be disrupted, resulting in immune system dysfunction or 'exhaustion.' An important protein called TO...

Idera Pharmaceuticals and Toll-like receptors

Dr. Sudhir Agrawal founded Idera Pharmaceuticals using the science that he studied as part of his post-doctoral research. Now this in depth understanding of the company’s core technology has enabled...

5 Top Weekly NASDAQ Biotech Stocks: Synergy on Top

Synergy Pharmaceuticals, Alpine Immune Sciences, Aerpio Pharmaceuticals, Correvio Pharma and Athersys were last week's top gainers. The post 5 Top Weekly NASDAQ Biotech Stocks: Synergy on Top appeared...

MGC Pharmaceuticals - MGC Derma sale completed

Edison Investment Research - Pharmaceuticals & healthcare - MGC Pharmaceuticals: Key milestones for MGC Pharmaceuticals in 2019 include the launch of CannEpil sales in Australia, finalising contrac...

An Immune System Clock to Predict Health and Longevity

PubMed Articles [1845 Associated PubMed Articles listed on BioPortfolio]

Occurrence and distribution of pharmaceuticals in raw, finished, and drinking water from seven large river basins in China.

The occurrence of pharmaceuticals in the drinking water is a growing concern in China. In this study, we determined the concentration and distribution of 59 selected pharmaceuticals in raw, finished, ...

Insight into the distribution of pharmaceuticals in soil-water-plant systems.

Pharmaceuticals in agricultural soils originating from irrigation with treated wastewater and land-applied biosolids can enter field crops. However, little is known about the role of pore water in pla...

U.S. Emergency Department Visits Resulting From Nonmedical Use of Pharmaceuticals, 2016.

National data on morbidity from nonmedical use of pharmaceuticals are limited. This study used nationally representative, public health surveillance data to characterize U.S. emergency department visi...

Exposure and ecotoxicological risk assessment of mixtures of top prescribed pharmaceuticals in Swedish freshwaters.

Surface water concentrations of 54 pharmaceuticals were predicted for seven major Swedish rivers and the Stockholm City area basins using the STREAM-EU model. These surface water concentrations were u...

Simultaneous aqueous chlorination of amine-containing pharmaceuticals.

Amine-containing pharmaceuticals such as acetaminophen, diclofenac, and sulfamethoxazole are the most often detected pharmaceuticals in wastewater and other aquatic environments. Amine-containing phar...

Clinical Trials [3567 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1844 Associated Companies listed on BioPortfolio]

Corvus Pharmaceuticals

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of small molecule and antibody agents that target the immune system to treat patien...

Immune Pharmaceuticals Inc.

Immune Pharmaceuticals Inc. (NASDAQ:IMNP) is dedicated to alleviating the burden of patients suffering from autoimmune diseases by developing novel immunotherapeutic agents. Immun...

Immune Pharmaceuticals, Inc.

Immune Pharmaceuticals is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Our lead program, bertilimuma...

Novis Pharmaceuticals

Novis Pharmaceuticals is a leading national distributor of some of the world's leading plasma-derived products such as albumin, immune globulin, hyperimmunes and anti-hemophilic Factors VII, VIII ...

Idera Pharmaceuticals, Inc. Idera Pharmaceuticals, Inc.

Idera Pharmaceuticals develops drug candidates to treat infectious diseases, autoimmune and inflammatory diseases, cancer, and respiratory diseases, and for use as vaccine adjuvan...

More Information about "Immune Pharmaceuticals Inc." on BioPortfolio

We have published hundreds of Immune Pharmaceuticals Inc. news stories on BioPortfolio along with dozens of Immune Pharmaceuticals Inc. Clinical Trials and PubMed Articles about Immune Pharmaceuticals Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Immune Pharmaceuticals Inc. Companies in our database. You can also find out about relevant Immune Pharmaceuticals Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record